![Curtis Head](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Curtis Head
Plus aucun poste en cours
Historique de carrière de Curtis Head
Anciens postes connus de Curtis Head
Sociétés | Poste | Début | Fin |
---|---|---|---|
Relevare Pharmaceuticals Ltd.
![]() Relevare Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Relevare Pharmaceuticals Ltd. develops novel therapies to treat chronic and acute pain. It gives treatment for acute or chronic severe pain and orally available NK1 antagonist combination therapies for the treatment of inflammatory and neuropathic pain. The company was founded in 2003 and is headquartered in Melbourne, Australia. | Directeur Technique/Scientifique/R&D | 18/08/2011 | - |
The University of California, San Francisco | Corporate Officer/Principal | 01/01/1996 | - |
Relevare Aust Pty Ltd.
![]() Relevare Aust Pty Ltd. Pharmaceuticals: MajorHealth Technology Relevare Aust Pty Ltd. develops innovative methods to treat diseases. The company was founded on August 9, 2004 and is headquartered in Abbotsford, Australia. | Corporate Officer/Principal | 24/05/2010 | - |
Formation de Curtis Head
San Francisco State University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 3 |
Australie | 3 |
Opérationnelle
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
Consumer Services | 3 |
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Relevare Aust Pty Ltd.
![]() Relevare Aust Pty Ltd. Pharmaceuticals: MajorHealth Technology Relevare Aust Pty Ltd. develops innovative methods to treat diseases. The company was founded on August 9, 2004 and is headquartered in Abbotsford, Australia. | Health Technology |
Relevare Pharmaceuticals Ltd.
![]() Relevare Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Relevare Pharmaceuticals Ltd. develops novel therapies to treat chronic and acute pain. It gives treatment for acute or chronic severe pain and orally available NK1 antagonist combination therapies for the treatment of inflammatory and neuropathic pain. The company was founded in 2003 and is headquartered in Melbourne, Australia. | Health Technology |
- Bourse
- Insiders
- Curtis Head
- Expérience